Patient Reported Outcomes/Metrics Program Trial

Recruiting now

Conditions studied: Metastatic Cancer, Palliative

In brief

This is an observational study to investigate if it is feasible to recruit 100 patients receiving radiotherapy (RT) to metastatic disease to wear Hexoskin and if Hexoskin will facilitate the monitoring, detection and early treatment of RT-related side effects.

Key facts

Study ID

NCT04983199

Run by

University Health Network, Toronto

People needed

100

Starts

2022-11-24

Expected to finish

2027-09-01

Last updated by the study team

2026-03-05

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Planned to receive palliative radiotherapy for pain
• Known cancer diagnosis
• Able to wear Hexoskin Medical Shirt
• Ability to use and populate the mobile app (Zamplo) with or without assistance
• ECOG: 0-3
• Willing to provide a list of analgesic (pain relief) medication
• Willing to complete questionnaires
• Life expectancy of at least 3 months

You may not qualify if…

• Receiving whole brain radiotherapy
• Major cognitive or psychiatric impairments
• Pregnant women
• Allergies to: polyester, synthetic fibers
• Patients with pacemakers or implantable cardioverter-defibrillator (ICD)
• Patients on a Holter Monitor

Where it is running

• Princess Margaret Cancer Centre — Toronto, Ontario, Canada (enrolling)

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.